Since ERK1/2 is known to phosphorylate Tau proteins on multiple sites through the Cyclin-dependent kinase 5 and its regulatory subunit p35 (cdk5/p35), the overactivation of these kinases may promote Tau pathology in AD. The gene discussed is MAPT; the disease is Alzheimer disease.